Stockscreener 앱 받기
61.96
1.42%
-0.89
시장 영업 전:
61.96
전일 마감가:
$62.85
열려 있는:
$63.05
하루 거래량:
140.01K
Relative Volume:
0.71
시가총액:
$942.96M
수익:
$780.99M
순이익/손실:
$64.42M
주가수익비율:
43.78
EPS:
1.4153
순현금흐름:
$62.40M
1주 성능:
-1.35%
1개월 성능:
-17.96%
6개월 성능:
-13.50%
1년 성능:
-17.82%
1일 변동 폭
$61.00
$63.07
1주일 범위
$60.35
$65.80
52주 변동 폭
$58.19
$93.50
U S Physical Therapy Inc Stock (USPH) Company Profile
명칭
U S Physical Therapy Inc
전화
(713) 297-7000
주소
1300 WEST SAM HOUSTON PARKWAY SOUTH, HOUSTON, TX
Compare USPH vs HCA, THC, DVA, FMS, EHC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
USPH
U S Physical Therapy Inc
|
61.96 | 956.50M | 780.99M | 64.42M | 62.40M | 1.4153 |
HCA
Hca Healthcare Inc
|
394.07 | 87.09B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
173.78 | 15.33B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
198.52 | 12.75B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.64 | 12.09B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.96 | 10.36B | 6.07B | 793.80M | 464.40M | 5.9914 |
U S Physical Therapy Inc Stock (USPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-10 | 재개 | Jefferies | Buy |
| 2025-09-18 | 재개 | JP Morgan | Overweight |
| 2024-12-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-12-16 | 개시 | JMP Securities | Mkt Outperform |
| 2024-10-07 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-09-22 | 개시 | JP Morgan | Overweight |
| 2023-06-30 | 개시 | BofA Securities | Buy |
| 2021-12-14 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2021-08-06 | 재확인 | Barrington Research | Outperform |
| 2021-05-07 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-05-03 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-02-26 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-06-08 | 재확인 | Barrington Research | Outperform |
| 2020-04-30 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-03-11 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-02-28 | 재확인 | Barrington Research | Outperform |
| 2019-11-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2019-03-08 | 개시 | William Blair | Outperform |
| 2017-11-03 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2017-09-08 | 업그레이드 | Sidoti | Neutral → Buy |
| 2017-07-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2017-03-17 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-11-04 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2016-08-05 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-05-06 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2016-03-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-11-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2015-05-06 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2013-12-12 | 재확인 | Dougherty & Company | Buy |
| 2013-08-23 | 재확인 | Dougherty & Company | Buy |
| 2013-01-14 | 재확인 | Dougherty & Company | Buy |
| 2010-07-09 | 개시 | JMP Securities | Mkt Outperform |
모두보기
U S Physical Therapy Inc 주식(USPH)의 최신 뉴스
USPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade) (NYSE:USPH) - Seeking Alpha
USPH Stock Price, Quote & Chart | U.S. PHYSICAL THERAPY INC (NYSE:USPH) - ChartMill
U.S. Physical Therapy Stock Stagnates at $65.04, Underperforms S&P 500News and Statistics - IndexBox
3 Reasons USPH is Risky and 1 Stock to Buy Instead - Yahoo Finance
Director at U S Physical Therapy (NYSE: USPH) receives stock grant - Stock Titan
U.S. Physical Therapy shareholders approve all proposals at annual meeting - Investing.com India
U.S. Physical Therapy (USPH) director granted 2,306 restricted shares at $61.61 - Stock Titan
[Form 4] U S PHYSICAL THERAPY INC /NV Insider Trading Activity - Stock Titan
US Physical Therapy (USPH) awards 2,306 restricted shares to director Harris - Stock Titan
U.S. Physical Therapy (USPH) director granted 2,306 restricted shares as equity pay - Stock Titan
U.S. Physical Therapy shareholders approve all proposals at annual meeting By Investing.com - Investing.com South Africa
US Physical Therapy Shareholders Back Board, Pay, Auditor - TipRanks
USPH (USPH) director Peter Minan discloses initial 125-share stake - Stock Titan
[8-K] U S PHYSICAL THERAPY INC /NV Reports Material Event - Stock Titan
U.S. Physical Therapy, Inc. Approves Election of Peter F. Minan as Director - marketscreener.com
US Physical Therapy (USPH) Q1 earnings and revenues lag estimates - MSN
Why It Might Not Make Sense To Buy U.S. Physical Therapy, Inc. (NYSE:USPH) For Its Upcoming Dividend - simplywall.st
Do These 3 Checks Before Buying U.S. Physical Therapy, Inc. (NYSE:USPH) For Its Upcoming Dividend - Yahoo Finance
Stock Movers on Tuesday: Helios Surges, Ulta Drops on Inflation Data | May 2026News and Statistics - IndexBox
U.S. Physical Therapy Q1 2026 Earnings: Margins Squeezed by Winter StormsNews and Statistics - IndexBox
Stocks making big moves yesterday: Helios, DraftKings, CACI, U.S. Physical Therapy, and Ulta - Yahoo Finance
U.S. Physical Therapy Stock Rises 4.5% After Q1 2026 Earnings BeatNews and Statistics - IndexBox
U.S. Physical Therapy’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Q1 2026 US Physical Therapy Inc Earnings Call Transcript - GuruFocus
(USPH) Volatility Zones as Tactical Triggers - Stock Traders Daily
U.S. Physical Therapy (USPH) Stock Is Up, What You Need To Know - Yahoo! Finance Canada
Is It Too Late to Buy US Physical Therapy Inc (USPH) After 8.2% Rally? GF Value Says Undervalued - GuruFocus
US Physical Therapy Price Target Cut to $90.00/Share From $103.00 by Barrington Research - Moomoo
U.S. Physical Therapy Presented at the BofA Securities 2026 Healthcare Conference - The Chronicle-Journal
USPH Maintained by Barrington Research -- Price Target Lowered t - GuruFocus
MSN Money - MSN
U.S. Physical Therapy, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:USPH) 2026-05-12 - Seeking Alpha
U.S. Physical Therapy Posts Strong Q1 2026 Revenue Growth - The Globe and Mail
User - FinancialContent
ETFs Investing in U.S. Physical Therapy, Inc. Stocks - TradingView
U.S. Physical Therapy posts Q1 revenue of $198M, reaffirms 2026 adjusted EBITDA guidance - TradingView
US Physical Therapy (NYSE: USPH) posts Q1 2026 growth and keeps EBITDA outlook - Stock Titan
A Look At U.S. Physical Therapy’s Valuation After Mixed Q1 2026 Earnings And Share Price Weakness - Sahm
TradingKey - TradingKey
U.S. Physical Therapy (USPH) Stock Price, News & Analysis - MarketBeat
Q1 2025 US Physical Therapy Inc Earnings Call Transcript - GuruFocus
U.S. Physical Therapy Balances Growth With Margin Strain - The Globe and Mail
U.S. Physical Therapy (NYSE: USPH) grows Q1 2026 revenue but EPS turns negative - Stock Titan
USPH Maintained by Citizens -- Price Target Lowered to $98.00 - GuruFocus
Copeland Capital holds 836,831 shares in U S PHYSICAL THERAPY (USPH) - Stock Titan
Bahl & Gaynor boosts passive stake in U S Physical Therapy (NYSE: USPH) 5.1% - Stock Titan
US Physical Therapy stock hits 52-week low at $65.89 By Investing.com - Investing.com Canada
U S Physical Therapy Inc (USPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.74%
0.15%
자본화:
|
볼륨(24시간):